151 related articles for article (PubMed ID: 27064715)
21. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease.
Siles R; Chen SE; Zhou M; Pinney KG; Trawick ML
Bioorg Med Chem Lett; 2006 Aug; 16(16):4405-9. PubMed ID: 16781147
[TBL] [Abstract][Full Text] [Related]
23. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
[TBL] [Abstract][Full Text] [Related]
24. Molecular Docking Studies Applied to a Dataset of Cruzain Inhibitors.
da Silva-Junior EF; Barcellos Franca PH; Ribeiro FF; Bezerra Mendonca-Junior FJ; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
Curr Comput Aided Drug Des; 2018; 14(1):68-78. PubMed ID: 28523999
[TBL] [Abstract][Full Text] [Related]
25. Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure-activity relationship studies.
de Souza AS; de Oliveira MT; Andricopulo AD
J Comput Aided Mol Des; 2017 Sep; 31(9):801-816. PubMed ID: 28795372
[TBL] [Abstract][Full Text] [Related]
26. Uncovering false positives on a virtual screening search for cruzain inhibitors.
Malvezzi A; de Rezende L; Izidoro MA; Cezari MH; Juliano L; do Amaral A
Bioorg Med Chem Lett; 2008 Jan; 18(1):350-4. PubMed ID: 17981033
[TBL] [Abstract][Full Text] [Related]
27. Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.
Hernández Alvarez L; Barreto Gomes DE; Hernández González JE; Pascutti PG
PLoS One; 2019; 14(1):e0211227. PubMed ID: 30682119
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach.
de Souza ML; de Oliveira Rezende Junior C; Ferreira RS; Espinoza Chávez RM; Ferreira LLG; Slafer BW; Magalhães LG; Krogh R; Oliva G; Cruz FC; Dias LC; Andricopulo AD
J Chem Inf Model; 2020 Feb; 60(2):1028-1041. PubMed ID: 31765144
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, activity, and molecular modeling studies of 1,2,3-triazole derivatives from natural phenylpropanoids as new trypanocidal agents.
de Souza TB; Caldas IS; Paula FR; Rodrigues CC; Carvalho DT; Dias DF
Chem Biol Drug Des; 2020 Jan; 95(1):124-129. PubMed ID: 31569301
[TBL] [Abstract][Full Text] [Related]
30. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
[TBL] [Abstract][Full Text] [Related]
31. Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment.
de Albuquerque S; Cianni L; de Vita D; Duque C; Gomes ASM; Gomes P; Laughton C; Leitão A; Montanari CA; Montanari R; Ribeiro JFR; da Silva JS; Teixeira C
Chem Biol Drug Des; 2020 Sep; 96(3):948-960. PubMed ID: 33058457
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi.
Silva-Júnior EF; Silva EPS; França PHB; Silva JPN; Barreto EO; Silva EB; Ferreira RS; Gatto CC; Moreira DRM; Siqueira-Neto JL; Mendonça-Júnior FJB; Lima MCA; Bortoluzzi JH; Scotti MT; Scotti L; Meneghetti MR; Aquino TM; Araújo-Júnior JX
Bioorg Med Chem; 2016 Sep; 24(18):4228-4240. PubMed ID: 27475533
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
Ferreira RS; Dessoy MA; Pauli I; Souza ML; Krogh R; Sales AI; Oliva G; Dias LC; Andricopulo AD
J Med Chem; 2014 Mar; 57(6):2380-92. PubMed ID: 24533839
[TBL] [Abstract][Full Text] [Related]
34. Aryl ureas represent a new class of anti-trypanosomal agents.
Du X; Hansell E; Engel JC; Caffrey CR; Cohen FE; McKerrow JH
Chem Biol; 2000 Sep; 7(9):733-42. PubMed ID: 10980453
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel benzimidazole derivatives as anti-Trypanosoma cruzi agents: solid-phase synthesis, structure-activity relationships and molecular docking studies.
Ríos N; Varela J; Birriel E; González M; Cerecetto H; Merlino A; Porcal W
Future Med Chem; 2013 Oct; 5(15):1719-32. PubMed ID: 24144409
[TBL] [Abstract][Full Text] [Related]
36. First quantum mechanics/molecular mechanics studies of the inhibition mechanism of cruzain by peptidyl halomethyl ketones.
Arafet K; Ferrer S; Moliner V
Biochemistry; 2015 Jun; 54(21):3381-91. PubMed ID: 25965914
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM
Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434
[TBL] [Abstract][Full Text] [Related]
38. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
[TBL] [Abstract][Full Text] [Related]
39. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies.
de Oliveira AS; Valli M; Ferreira LL; Souza JM; Krogh R; Meier L; Abreu HR; Voltolini BG; Llanes LC; Nunes RJ; Braga AL; Andricopulo AD
Future Med Chem; 2022 Jun; 14(11):795-808. PubMed ID: 35543430
[No Abstract] [Full Text] [Related]
40. Highly predictive hologram QSAR models of nitrile-containing cruzain inhibitors.
Silva DG; Rocha JR; Sartori GR; Montanari CA
J Biomol Struct Dyn; 2017 Nov; 35(15):3232-3249. PubMed ID: 27809673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
